EMA will continue to work on therapeutics. 💊
We will monitor any new antivirals that are easier to administer, and any monoclonal antibodies targeting new variants, which could improve the protection of the vulnerable against #COVID19.
🐦🔗: https://n.respublicae.eu/EMA_News/status/1666078996596129797
EMA-@ECDC_EU recommendation: A monovalent #vaccine including an XBB strain is recommended for the update of vaccines to be used in the autumn vaccination campaigns.
Updated vaccines could be used for revaccination, but also for primary vaccination.
🐦🔗: https://n.respublicae.eu/EMA_News/status/1666078341395542017
Without #COVID19vaccines we wouldn’t have overcome the pandemic.
They will continue to be key public health interventions in the months and years to come. #EMAPresser
🐦🔗: https://n.respublicae.eu/EMA_News/status/1666077875903279105
#COVID19 caused and continues to cause a significant strain on public health systems, especially during winter. Public health authorities will have to keep their guard up. #EMAPresser
🐦🔗: https://n.respublicae.eu/EMA_News/status/1666077652078460929
It is estimated that in the 1st year of the pandemic, #COVID19vaccines saved almost 20 million lives.
This press event marks the 🔚 of our regular updates. If the need arises, we will hold such briefings again. We need the media to continue to report about science.
🐦🔗: https://n.respublicae.eu/EMA_News/status/1666077388558696453
Fast-track scientific advice, accelerated vaccine approvals and collaboration with our 🇪🇺 partners have led to the authorisation of
8⃣ #Covid19vaccines 💉
8⃣ #Covid19treatments 💊
enabling the largest vaccination programme in Europe's history.
🐦🔗: https://n.respublicae.eu/EMA_News/status/1666076904586375168
EMA today is different from the Agency that entered the #pandemic.
We learned to be more flexible and agile in the way we work.
Over the course of the crisis we assumed a range of new responsibilities which became part of our extended mandate in March 2022.
🐦🔗: https://n.respublicae.eu/EMA_News/status/1666076611639414785
During the pandemic media have helped us maintain trust in our work. Through their questions about #Covid19vaccines and #science, their follow-up of citizens' concerns, the public was kept informed about the approval process and the role of the medicines regulator. #EMAPresser
🐦🔗: https://n.respublicae.eu/EMA_News/status/1666076400456196104
Watch live 🔴
We are now starting our final regular press briefing on EMA’s response to #COVID19 pandemic and other public health emergencies. Don’t miss our tweets during the press briefing.
Follow #EMAPresser.
🧵
🐦🔗: https://n.respublicae.eu/EMA_News/status/1666075442691084289
EMA's last regular press briefing on #PublicHealth emergencies https://n.respublicae.eu/i/broadcasts/1OwxWwQPZbNxQ
🐦🔗: https://n.respublicae.eu/EMA_News/status/1666075256359112704
‼️ EMA holds its last regular press briefing on #PublicHealth emergencies.
It will be broadcast live 🔴 today, 6 June, from 15:30 to 16:00 CEST. #EMAPresser #COVID19
👉 https://www.ema.europa.eu/en/events/ema-regular-press-briefing-public-health-emergencies-2
🐦🔗: https://n.respublicae.eu/EMA_News/status/1666067623392559104
COVID-19 is no longer a public health emergency, but surveillance, preparedness & coordination remain key
Timely vaccination ahead of a potential 2023 autumn/winter surge will help protect people from severe illness & keep health systems working
#UnitedInProtection
#HealthUnion
RT @EMA_News: ‼️ We have published joint recommendations with @ECDC_EU on:
👉adapted #COVID19vaccines to target XBB strains
👉their use in autumn 2023 vaccination campaigns
Read more in th…
🐦🔗: https://n.respublicae.eu/EU_Health/status/1666062075028729856
#RSV - respiratory syncytial virus - causes an estimated 17000 in-hospital deaths each year in Europe
Today, we authorised the 1st vaccine to protect adults aged 60+ from lower respiratory tract disease caused by the virus
https://europa.eu/!R3bWtw
#UnitedInProtection #HealthUnion
🐦🔗: https://n.respublicae.eu/EU_Health/status/1666025972691288064
‼️ We have published joint recommendations with @ECDC_EU on:
👉adapted #COVID19vaccines to target XBB strains
👉their use in autumn 2023 vaccination campaigns
Read more in the joint statement:
https://www.ema.europa.eu/en/news/ema-ecdc-statement-updating-covid-19-vaccines-target-new-sars-cov-2-virus-variants
🐦🔗: https://n.respublicae.eu/EMA_News/status/1666055344563290114
🚨Don't miss the #InfoDay tomorrow!
Join us to learn more about the application process for the 4th Call for proposals under the #DigitalEuropeProgramme
📍 7 June, 10.00 (CEST)
Send your questions now via #Slido, using the hashtag #HADEA ⤵️
🐦🔗: https://n.respublicae.eu/EU_HaDEA/status/1665987413255102464
RT @EU_Health: 📢 New digital health initiative to strengthen global health security:
The @WHO will take up the EU system of digital COVID-19 certification, a first building block of the WHO Global Digital Health Certification Network.
Read more ⬇
#EUGlobalHealthStrategy
#HealthUnion
🐦🔗: https://n.respublicae.eu/EMA_News/status/1665676150280953863
RT @EU_Health: Watch live on EBS+ from +/- 12h30 CET:
🔗https://audiovisual.ec.europa.eu/en/ebs/live/2
The presentation of the WHO Global Digital Certification Network uptake ceremony with @SKyriakidesEU and @DrTedros from @WHO
#EUGlobalHealthStrategy
#HealthUnion @DigitalEU https://t.co/TP6S5fBhi2 https://t.co/aowgrwR5h9
🐦🔗: https://n.respublicae.eu/EMA_News/status/1665675809812623362
Have you been affected by the shortage of the medicine Ozempic❓ #diabetes
Participate in our #survey and help us improve our communication!
The aim is to collect information on how patients were informed about the recent medicine #shortages.
📩 Send your feedback by 9 June
🐦🔗: https://n.respublicae.eu/EMA_News/status/1665614429688573952
The #AlternativesToAnimalTesting workshop has finished, and we couldn't be more grateful to the 500 stakeholders who attended from member states, academia, NGOs, industry, etc.
Recordings and presentations of the sessions are now available online 🔗https://lnkd.in/egt4ABrP
🐦🔗: https://n.respublicae.eu/EU_ECHA/status/1664296170045202441
RT @SandraGallina: With #EUCancerPlan and #MissionCancer we are turning the tide on cancer.
➡ Learn about ambitious #EU4Health funded projects, making a difference to prevention, early detection, treatment and life after cancer.
https://health.ec.europa.eu/non-communicable-diseases/cancer/europes-beating-cancer-plan-eu4health-financed-projects_en
🐦🔗: https://n.respublicae.eu/EMA_News/status/1664582604652249089
Unofficial automated mirror. No copyright asserted. ∎ Latest news from the European Medicines Agency, the European Union agency responsible for the evaluation and supervision of medicines. RTs ≠ endorsement.